Low-Dose vs Full-Dose Apixaban in VTE: What Does AMPLIFY-EXT Trial Tell Us?
A short review of the AMPLIFY-EXT trial which evaluated the use of apixaban at 2.5 mg BID and 5 mg BID vs placebo for the prophylaxis of VTE after an initial course of anticoagulation
